By analyzing the fragmented cell-free DNA (cfDNA) found in urine, it may be possible to gain diagnostic insights from this degraded genetic material, according to a new study appearing in Science Translational Medicine this week. While cancer-derived cfDNA is present in urine, it is highly fragmented, limiting targeted analysis of genomic alterations.